Jean‐Baptiste Julla

644 total citations
22 papers, 176 citations indexed

About

Jean‐Baptiste Julla is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Jean‐Baptiste Julla has authored 22 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Genetics and 5 papers in Surgery. Recurrent topics in Jean‐Baptiste Julla's work include Diabetes Management and Research (9 papers), Diabetes and associated disorders (6 papers) and Diabetes Treatment and Management (4 papers). Jean‐Baptiste Julla is often cited by papers focused on Diabetes Management and Research (9 papers), Diabetes and associated disorders (6 papers) and Diabetes Treatment and Management (4 papers). Jean‐Baptiste Julla collaborates with scholars based in France, Luxembourg and Kuwait. Jean‐Baptiste Julla's co-authors include Jean–François Gautier, Jean‐Pierre Riveline, Nicolas Venteclef, Tiphaine Vidal-Trécan, Ronan Roussel, Louis Potier, Marc Diedisheim, Bénédicte Gaborit, Fawaz Alzaïd and Louise Basmaciyan and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Jean‐Baptiste Julla

16 papers receiving 174 citations

Peers

Jean‐Baptiste Julla
Jean‐Baptiste Julla
Citations per year, relative to Jean‐Baptiste Julla Jean‐Baptiste Julla (= 1×) peers Marion Venot

Countries citing papers authored by Jean‐Baptiste Julla

Since Specialization
Citations

This map shows the geographic impact of Jean‐Baptiste Julla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Baptiste Julla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Baptiste Julla more than expected).

Fields of papers citing papers by Jean‐Baptiste Julla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Baptiste Julla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Baptiste Julla. The network helps show where Jean‐Baptiste Julla may publish in the future.

Co-authorship network of co-authors of Jean‐Baptiste Julla

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Baptiste Julla. A scholar is included among the top collaborators of Jean‐Baptiste Julla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Baptiste Julla. Jean‐Baptiste Julla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallo, Linda A., Katina D. Hulme, Fawaz Alzaïd, et al.. (2025). Measurement of serum 1,5-AG provides insights for diabetes management and the anti-viral immune response. Cellular and Molecular Life Sciences. 82(1). 71–71.
2.
Julla, Jean‐Baptiste, Guy Fagherazzi, Pierre Gourdy, et al.. (2025). Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort. Cardiovascular Diabetology. 24(1). 256–256. 1 indexed citations
3.
Julla, Jean‐Baptiste, et al.. (2025). Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort. Diabetes & Metabolism. 51(6). 101700–101700.
4.
Picard, Sylvie, Jean‐Pierre Riveline, Jean‐Baptiste Julla, et al.. (2025). Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study. Diabetes & Metabolism. 51(4). 101647–101647.
5.
Vidal-Trécan, Tiphaine, Jean‐Baptiste Julla, Nicolas Venteclef, et al.. (2025). Effectiveness of Six International Guidelines Using Fibrosis-4 and FibroScan for Risk Stratification of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes. Clinical Gastroenterology and Hepatology. 23(12). 2176–2186.e2. 2 indexed citations
6.
Lablanche, Sandrine, Jean‐Baptiste Julla, Fanny Buron, et al.. (2025). Automated insulin delivery after beta-cell replacement failure in people living with type 1 diabetes. Diabetes & Metabolism. 51(4). 101654–101654. 1 indexed citations
8.
Ancel, Patricia, Jean‐Charles Martin, Pierre Gascon, et al.. (2023). Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy. International Journal of Molecular Sciences. 24(15). 12053–12053. 15 indexed citations
9.
Diedisheim, Marc, Catherine Pecquet, Jean‐Baptiste Julla, et al.. (2023). Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study. Diabetes Technology & Therapeutics. 25(4). 279–286. 13 indexed citations
10.
Riveline, Jean‐Pierre, Roberto Mallone, F. Travert, et al.. (2023). Validation of the Body Scan®, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan®. Frontiers in Neurology. 14. 1256984–1256984. 3 indexed citations
11.
Ostertag, Agnès, Martine Cohen‐Solal, Fawaz Alzaïd, et al.. (2023). New ex vivo method to objectively assess insulin spatial subcutaneous dispersion through time during pump basal-rate based administration. Scientific Reports. 13(1). 20052–20052. 1 indexed citations
12.
Castéra, Laurent, Tiphaine Vidal-Trécan, Jean‐Baptiste Julla, et al.. (2023). Head-to-head comparison of Agile 3+, LSM-VCTE, NFS, and FIB-4 scores for detecting advanced fibrosis in patients with type 2 diabetes seen in diabetes clinic. Journal of Hepatology. 78. S681–S682. 1 indexed citations
13.
Julla, Jean‐Baptiste, Ali Erginay, Tiphaine Vidal-Trécan, et al.. (2021). Prevalence, severity stages, and risk factors of diabetic retinopathy in 1464 adult patients with type 1 diabetes. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(12). 3613–3623. 7 indexed citations
14.
Ponfilly, Gauthier Péan de, Louis Potier, M. Laloi‐Michelin, et al.. (2021). Reliability and Safety of Bedside Blind Bone Biopsy Performed by a Diabetologist for the Diagnosis and Treatment of Diabetic Foot Osteomyelitis. Diabetes Care. 44(11). 2480–2486. 10 indexed citations
15.
Julla, Jean‐Baptiste, Guy Fagherazzi, Tiphaine Vidal-Trécan, et al.. (2021). Is the Consensual Threshold for Defining High Glucose Variability Implementable in Clinical Practice?. Diabetes Care. 44(7). 1722–1725. 18 indexed citations
16.
Alzaïd, Fawaz, Jean‐Baptiste Julla, Marc Diedisheim, et al.. (2020). Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID ‐19 in type 2 diabetes. EMBO Molecular Medicine. 12(10). e13038–e13038. 37 indexed citations
17.
Julla, Jean‐Baptiste, et al.. (2020). The use of statins in the elderly is associated with less severe hypoglycemia in patient with diabetes. Diabetes Research and Clinical Practice. 162. 108034–108034.
18.
Ménégaut, Louise, Charles Thomas, Antoine Jalil, et al.. (2020). Interplay between Liver X Receptor and Hypoxia Inducible Factor 1α Potentiates Interleukin-1β Production in Human Macrophages. Cell Reports. 31(7). 107665–107665. 43 indexed citations
19.
Froelich, Sébastien, et al.. (2020). Towards individualised and optimalised positioning of non-ventilated COVID-19 patients: Putting the affected parts of the lung(s) on top?. Diabetes & Metabolism. 47(2). 101167–101167. 7 indexed citations
20.
Julla, Jean‐Baptiste, et al.. (2019). Isolation and Analysis of Human Monocytes and Adipose Tissue Macrophages. Methods in molecular biology. 1951. 33–48. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026